NasdaqGS

CMAXW

Cambridge Cognition Holdings plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB Recruit, an online trial recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases I"IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital health solutions for the enhancement of patient engagement, demonstration of treatment efficacy, and understanding of a disease and a patient's response to medication. It also provides CANTAB Connect Research, a research software that offers sensitive digital measures of cognitive function for various areas of brain research; CANTAB Mobile, a touchscreen memory test used in clinical research of Alzheimer's disease; CANTAB BrainHealth, an online digital health assessment tool to measure and monitor mental wellbeing and cognitive performance in the workplace; CANTAB Insight, a medical device that helps to determine an individual's cognitive health; and NeuroVocalix for an automated administration and scoring of well-validated verbal cognitive assessments"on a secure platform. In addition, the company offers a range of expert consultancy and operational management services to optimize clinical trials and cognitive research, which include neuroscience and technical consultancy, study design, data analysis, study and data management, and reports and interpretation. Cambridge Cognition Holdings plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.

COG.L

XETRA

COP.DE

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers InSight Denials to analyze, track, trend, and report on denial data; Trisus Healthcare Intelligence, a solution that provides insights into resource consumption on the patient level; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Sentrex 330; Referral Verification System; and Sentry Core, a solution that simplifies the complexities of pharmacy procurement, utilization, and compliances. Further, it offers appeal and professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

CRW.L

NYSE

DOCS

DeepVerge plc, an environmental and life science artificial intelligent company, develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus, and toxins. The company offers Labskin, a commercially available lab-grown, full thickness human skin to support product research and development activities in the cosmetic, personal care, medical device, and pharmaceutical sectors; Rinocloud, a data infrastructure as a service that delivers secure intelligent store, share and search, encryption, and infrastructure technologies; and skin trust club, a skin health tracking using advanced sequencing, bioinformatics, and AI algorithms. It also provides regulated environmental toxicology services; human skin equivalent platform to validate and verify the safety and impact on client products for regulatory authority approval; AI and microbiome platform to facilitate clinical trials for skincare companies and remote test-kits for consumer skin; and monitoring and data analytics platform for real-time detection and identification of pathogens in water and wastewater treatment plants, drinking water, rivers, lakes, and reservoirs. In addition, the company offers a range of skin care products and cannabinoid oils. It operates in the United Kingdom, rest of Europe, the United States, and internationally. The company was formerly known as Integumen plc and changed its name to DeepVerge plc in October 2020. The company was incorporated in 2016 and is headquartered in Malahide, Ireland.

DVRG.L

EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web, which enables patients to order repeat medication online and track progress from order to home delivery; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom.

EMIS.L

NasdaqCM

ETAO

EUDA

EUDAW

Feedback plc, a medical imaging technology company, provides software and systems to those working in the field of medical imaging. Its products include TexRAD, a patent-protected software tool, which extracts and quantifies texture features in in pre-existing medical images, explore texture biomarkers for research into diseases like cancer, and uncovers biomarkers in medical images; and TexRAD Lung, a software tool for the analysis of lung cancer for clinical use in the European Union. The company also offers Cadran image platform that provides comprehensive picture archiving storage, management, and display system for medical images, as well as equips users with a platform for medical image handling from all imaging modalities; and Bleepa, a secure clinical communications platform that facilitates the sharing of clinical-grade medical images. Feedback plc was incorporated in 1958 and is headquartered in London, the United Kingdom.

FDBK.L

FORA

GDRX

GE HealthCare Technologies Inc. is a company specializing in developing, manufacturing, and marketing a wide range of healthcare products and digital solutions for patient diagnosis, treatment, and monitoring, globally. It operates through four main segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics, each offering specialized products and services such as CT scans, MR imaging, ultrasound solutions, patient monitoring devices, and diagnostic agents. 

Symbol	Full Name	Sector	Industry	YTD Return	10Y Return (Annualized)	Dividend Yield
CMAXW	CareMax Inc	Healthcare	Health Information Services	40.00%	—	0.00%
COG.L	Cambridge Cognition Holdings plc	Healthcare	Health Information Services	0.97%	-1.74%	0.00%
COP.DE	CompuGroup Medical SE & Co. KGaA	Healthcare	Health Information Services	-24.41%	5.11%	1.75%
CRW.L	Craneware plc	Healthcare	Health Information Services	24.16%	16.80%	0.01%
DH	Definitive Healthcare Corp.	Healthcare	Health Information Services	-29.68%	—	0.00%
DOCS	Doximity, Inc.	Healthcare	Health Information Services	-15.05%	—	0.00%
DVRG.L	Deepverge plc	Healthcare	Health Information Services	—	—	—
EMIS.L	EMIS Group plc	Healthcare	Health Information Services	—	—	—
ETAO	Etao International Co. Ltd. Ordinary Shares	Healthcare	Health Information Services	-66.67%	—	0.00%
EUDA	EUDA Health Holdings Limited	Healthcare	Health Information Services	37.06%	—	0.00%
EUDAW	EUDA Health Holdings Limited	Healthcare	Health Information Services	94.81%	—	0.00%
EVH	Evolent Health, Inc.	Healthcare	Health Information Services	-16.29%	—	0.00%
FDBK.L	Feedback plc	Healthcare	Health Information Services	44.44%	-5.03%	0.00%
FORA	Forian Inc.	Healthcare	Health Information Services	-7.01%	—	0.00%
GDRX	GoodRx Holdings, Inc.	Healthcare	Health Information Services	7.31%	—	0.00%
GEHC	GE HealthCare Technologies Inc.	Healthcare	Health Information Services	11.62%	—	0.17%
HCAT	Health Catalyst, Inc.	Healthcare	Health Information Services	-34.88%	—	0.00%
HCTI	Healthcare Triangle, Inc.	Healthcare	Health Information Services	-53.73%	—	0.00%
HLTH	Cue Health Inc.	Healthcare	Health Information Services	-13.23%	—	0.00%
HQY	HealthEquity, Inc.	Healthcare	Health Information Services	21.06%	—	0.00%

Health Information Services Stock List